LGI1 Antikörper (AA 35-557)
Kurzübersicht für LGI1 Antikörper (AA 35-557) (ABIN7874172)
Target
Alle LGI1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 35-557
-
Verwendungszweck
- LGI1 Antibody / Leucine-rich glioma inactivated 1
-
Aufreinigung
- Affinity purified
-
Immunogen
- Recombinant human protein (amino acids K35-A557) was used as the immunogen for the LGI1 antibody.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal dilution of the LGI1 antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- After reconstitution, the LGI1 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
-
-
- LGI1 (Leucine-Rich, Glioma Inactivated 1 (LGI1))
-
Andere Bezeichnung
- LGI1
-
Hintergrund
- Leucine-rich, glioma inactivated 1, also known as LGI1, is a protein which in humans is encoded by the LGI1 gene. This gene encodes a member of the secreted leucine-rich repeat (LRR) superfamily and shares homology with members of the SLIT protein family. The encoded protein may regulate the activity of voltage-gated potassium channels and may be involved in neuronal growth regulation and cell survival. This gene is rearranged as a result of translocations in glioblastoma cell lines, and it is frequently down-regulated or rearranged in malignant gliomas. Mutations in this gene result in autosomal dominant lateral temporal epilepsy. Alternative splicing results in multiple transcript variants.
-
UniProt
- O95970
Target
-